1/13
06:40 am
aort
1 Profitable Stock with Exciting Potential and 2 Facing Headwinds [Yahoo! Finance]
Low
Report
1 Profitable Stock with Exciting Potential and 2 Facing Headwinds [Yahoo! Finance]
1/5
07:42 am
aort
Assessing Artivion (AORT) Valuation After Strong Recent Returns And Ongoing Net Loss [Yahoo! Finance]
Low
Report
Assessing Artivion (AORT) Valuation After Strong Recent Returns And Ongoing Net Loss [Yahoo! Finance]
1/5
06:50 am
aort
1 Healthcare Stock on Our Watchlist and 2 We Ignore [Yahoo! Finance]
Low
Report
1 Healthcare Stock on Our Watchlist and 2 We Ignore [Yahoo! Finance]
12/29
02:07 pm
aort
Artivion Continues Building Toward Bigger And Better Things [Seeking Alpha]
Low
Report
Artivion Continues Building Toward Bigger And Better Things [Seeking Alpha]
12/29
10:16 am
aort
1 Safe-and-Steady Stock on Our Watchlist and 2 We Avoid [Yahoo! Finance]
Low
Report
1 Safe-and-Steady Stock on Our Watchlist and 2 We Avoid [Yahoo! Finance]
12/21
01:08 am
aort
Low
Report
12/18
07:28 am
aort
3 Cash-Producing Stocks with Questionable Fundamentals [Yahoo! Finance]
Low
Report
3 Cash-Producing Stocks with Questionable Fundamentals [Yahoo! Finance]
12/17
04:15 pm
aort
Artivion (AORT) Stock Is Up, What You Need To Know [Yahoo! Finance]
Low
Report
Artivion (AORT) Stock Is Up, What You Need To Know [Yahoo! Finance]
12/17
07:06 am
aort
Artivion (NYSE:AORT) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Low
Report
Artivion (NYSE:AORT) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
11/27
02:33 pm
aort
Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Low
Report
Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
11/26
06:07 am
aort
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Artivion (NYSE:AORT) Vs The Rest [Yahoo! Finance]
Low
Report
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Artivion (NYSE:AORT) Vs The Rest [Yahoo! Finance]
11/15
07:05 pm
aort
Strong Q3 Results and Raised Outlook Could Be a Game Changer for Artivion (AORT) [Yahoo! Finance]
Low
Report
Strong Q3 Results and Raised Outlook Could Be a Game Changer for Artivion (AORT) [Yahoo! Finance]
11/11
09:26 am
aort
2 Unpopular Stocks That Deserve a Second Chance and 1 Facing Challenges [Yahoo! Finance]
Medium
Report
2 Unpopular Stocks That Deserve a Second Chance and 1 Facing Challenges [Yahoo! Finance]
11/9
07:03 pm
aort
Artivion (AORT): Is the Healthcare Standout Fairly Valued After Recent Surge? [Yahoo! Finance]
Low
Report
Artivion (AORT): Is the Healthcare Standout Fairly Valued After Recent Surge? [Yahoo! Finance]
11/7
11:01 pm
aort
Artivion's (NYSE:AORT) Q3 Sales Top Estimates [Yahoo! Finance]
Low
Report
Artivion's (NYSE:AORT) Q3 Sales Top Estimates [Yahoo! Finance]
11/7
04:57 pm
aort
Artivion (NYSE:AORT) had its price target raised by analysts at Canaccord Genuity Group Inc. from $50.00 to $51.00. They now have a "buy" rating on the stock.
Low
Report
Artivion (NYSE:AORT) had its price target raised by analysts at Canaccord Genuity Group Inc. from $50.00 to $51.00. They now have a "buy" rating on the stock.
11/7
09:05 am
aort
Artivion (NYSE:AORT) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Medium
Report
Artivion (NYSE:AORT) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
11/7
08:41 am
aort
Artivion (NYSE:AORT) had its price target raised by analysts at Citizens Jmp from $47.00 to $53.00. They now have a "market outperform" rating on the stock.
Medium
Report
Artivion (NYSE:AORT) had its price target raised by analysts at Citizens Jmp from $47.00 to $53.00. They now have a "market outperform" rating on the stock.
11/7
08:07 am
aort
Artivion (NYSE:AORT) had its price target raised by analysts at Needham & Company LLC from $50.00 to $58.00. They now have a "buy" rating on the stock.
Medium
Report
Artivion (NYSE:AORT) had its price target raised by analysts at Needham & Company LLC from $50.00 to $58.00. They now have a "buy" rating on the stock.
11/6
11:47 pm
aort
Artivion outlines double-digit revenue growth target for 2025 as AMDS and On-X momentum builds [Seeking Alpha]
Medium
Report
Artivion outlines double-digit revenue growth target for 2025 as AMDS and On-X momentum builds [Seeking Alpha]
11/6
04:52 pm
aort
Artivion Non-GAAP EPS of $0.16 beats by $0.01, revenue of $113.4M beats by $2.81M [Seeking Alpha]
Medium
Report
Artivion Non-GAAP EPS of $0.16 beats by $0.01, revenue of $113.4M beats by $2.81M [Seeking Alpha]
11/6
04:36 pm
aort
Artivion Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Medium
Report
Artivion Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
11/6
04:05 pm
aort
Artivion Reports Third Quarter 2025 Financial Results
Medium
Report
Artivion Reports Third Quarter 2025 Financial Results
11/6
08:00 am
aort
Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial
Low
Report
Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial
10/31
08:08 pm
aort
Why Artivion (AORT) Is Up 5.2% After Raising Its 2024 Outlook and Highlighting Product Momentum [Yahoo! Finance]
Low
Report
Why Artivion (AORT) Is Up 5.2% After Raising Its 2024 Outlook and Highlighting Product Momentum [Yahoo! Finance]